0 items USD 0.00Search
- Did you mean
- psoriasis arthritis
Your search for "psoriatic arthritis" gave back 2456 results.
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
September 2024
Price: USD 3,950.00
Adalimumab, sold under the trade name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
December 2024
Price: USD 4,900.00
The global Adalimumab market size was valued at USD 150.2 million in 2023 and is forecast to a readjusted size of USD 201.8 million by 2030 with a...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
December 2024
Price: USD 3,480.00
The global Rheumatic Disorders Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Rheumatic Disorders...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
March 2024
Price: USD 3,660.00
The global Arthritic Therapeutic market size was valued at US$ 26650 million in 2023. With growing demand in downstream market, the Arthritic...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
March 2024
Price: USD 3,660.00
Tofacitinib citrate extended-release tablets refer to a specific pharmaceutical formulation of tofacitinib citrate,a Janus kinase(JAK)inhibitor used...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
August 2024
Price: USD 2,900.00
Treatment of drugs for regulating rheumatic diseases Â鶹Դ´ Analysis and Insights: Global Rheumatic Disorders Drug Â鶹Դ´ The global Rheumatic...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
June 2023
Price: USD 4,900.00
Â鶹Դ´ Analysis and Insights: Global Arthritic Therapeutic Â鶹Դ´ The global Arthritic Therapeutic market is projected to grow from US$ 28340 million...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
May 2023
Price: USD 4,900.00
Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor. The global Tumor Necrosis Factor Inhibitor Drug...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
February 2024
Price: USD 2,900.00
Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor. Highlights The global Tumor Necrosis Factor...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
February 2023
Price: USD 2,900.00
Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
Global Â鶹Դ´s Direct
July 2018
Price: USD 3,500.00
Treatment of drugs for regulating rheumatic diseases Â鶹Դ´ Analysis and Insights: Global Rheumatic Disorders Drug Â鶹Դ´ The global Rheumatic...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
December 2024
Price: USD 4,900.00
The global Infliximab and Biosimilar market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
June 2024
Price: USD 3,480.00
Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that explicitly targets enzymes responsible for inflammation and pain namely...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
May 2023
Price: USD 4,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
March 2023
Price: USD 4,900.00
Ìý
